Status | Study |
Completed |
Study Name: Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis Condition: Actinic Keratosis Bowen's Disease Date: 2014-03-11 Interventions: Drug: SR-T100 ® Gel Other Name: SR-T100 |
Completed |
Study Name: Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease Condition: Bowen's Disease Date: 2013-07-09 Interventions: Drug: Er:YAG AFL-PDT Er:YAG AF |
No longer available |
Study Name: Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease Condition: Field Actinic Keratoses Basal Cell Carcinoma Date: 2007-09-21 Interventions: Drug: Metvix (methyl aminolevulinate) Metvix (methyl aminolevulinate) (MAL), Photodynamic Therapy (PDT), |
Terminated |
Study Name: Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease Condition: Bowen's Disease Date: 2007-05-10 Interventions: Procedure: excision excision 3 |
Completed |
Study Name: PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer Condition: Actinic Keratosis Warts Basal Cell Carcinoma Date: 2007-05-10 Interventions: Procedure: Photodynamic therapy with Metvix 160 mg/g cream |
Not yet recruiting |
Study Name: Topical Imiquimod for Bowen's Disease of the Head and Neck Condition: Bowens Disease Date: 2006-10-04 Interventions: Drug: Imiquimod Imiquimod application M-F for six weeks (total of 30 applications) followed by surgical |
Completed |
Study Name: Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ Condition: Carcinoma, Squamous Cell Date: 2006-05-22 Interventions: Drug: PEP005 |
Completed |
Study Name: Effects of Arsenic on Keratinocytes in a Skin Equivalent Model Condition: Bowen Disease Date: 2005-09-12 Interventions: Procedure: foreskin from healthy adults for organotypic culture |
Completed |
Study Name: Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides Condition: Lymphoma Non-melanomatous Skin Cancer Precancerous Conditi Date: 2005-02-07 Interventions: Drug: silicon phthalocyanine 4 Patients receive topical silicon phthalocyanine 4 (Pc 4). One hour later, |
Recruiting |
Study Name: Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial Condition: Date: 2024-04-26 |